Kis, A.M.; Macasoi, I.; Paul, C.; Radulescu, M.; Buzatu, R.; Watz, C.G.; Cheveresan, A.; Berceanu, D.; Pinzaru, I.; Dinu, S.;
et al. Methotrexate and Cetuximab—Biological Impact on Non-Tumorigenic Models: In Vitro and In Ovo Assessments. Medicina 2022, 58, 167.
https://doi.org/10.3390/medicina58020167
AMA Style
Kis AM, Macasoi I, Paul C, Radulescu M, Buzatu R, Watz CG, Cheveresan A, Berceanu D, Pinzaru I, Dinu S,
et al. Methotrexate and Cetuximab—Biological Impact on Non-Tumorigenic Models: In Vitro and In Ovo Assessments. Medicina. 2022; 58(2):167.
https://doi.org/10.3390/medicina58020167
Chicago/Turabian Style
Kis, Andreea M., Ioana Macasoi, Corina Paul, Matilda Radulescu, Roxana Buzatu, Claudia G. Watz, Adelina Cheveresan, Delia Berceanu, Iulia Pinzaru, Stefania Dinu,
and et al. 2022. "Methotrexate and Cetuximab—Biological Impact on Non-Tumorigenic Models: In Vitro and In Ovo Assessments" Medicina 58, no. 2: 167.
https://doi.org/10.3390/medicina58020167
APA Style
Kis, A. M., Macasoi, I., Paul, C., Radulescu, M., Buzatu, R., Watz, C. G., Cheveresan, A., Berceanu, D., Pinzaru, I., Dinu, S., Manea, A., Poenaru, M., Borza, C., & Dehelean, C. A.
(2022). Methotrexate and Cetuximab—Biological Impact on Non-Tumorigenic Models: In Vitro and In Ovo Assessments. Medicina, 58(2), 167.
https://doi.org/10.3390/medicina58020167
